The new, imposed NHS (Pharmaceutical and Local Pharmaceutical Services) (PLPS) Regulations 2013 come into force tomorrow, 25 May 2023, and introduce: a ‘notification’ procedure for 100-hour pharmacies to reduce their total weekly core opening hours to no less than 72 hours, subject to various requirements; a notification procedure for introducing or changing rest breaks, by
Read moreIt will soon be time for community pharmacy owners to verify their NHS Profile Manager profile information. Ahead of the 30th June 2023 deadline, we would like to remind members of the need for you to update NHS Profile Manager to ensure that your pharmacy’s NHS website and Directory of Services (DoS) profile information is kept up-to-date.
Read moreContractors (including head office staff) and community pharmacists have one month left to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The
Read moreThe Department of Health and Social Care (DHSC) has today (24/05/2023) granted the following list of price concessions for May 2023: Drug Pack size Price concession Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.42 Amoxicillin 250mg/5ml oral suspension sugar free 100 £3.50 Atorvastatin 20mg tablets 28 £1.56 Bimatoprost 100micrograms/ml eye drops 3 £3.99 Clarithromycin 250mg/5ml oral
Read moreClass 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited) Drug alert number: EL (23)A/19 Date issued: 23 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Metronidazole 200 mg/5 ml Oral Suspension, PL 30684/0236 Batch No
Read moreClass 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) Drug alert number: EL (23)A/18 Date issued: 22 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272 Batch No Expiry Date
Read moreCommunity pharmacy contractors are not required to undertake a contractor-chosen or an NHS England determined clinical audit in 2023/24. This follows PSNC’s request to remove this clinical governance requirement for contractors in 2023/24. A clinical audit on anticoagulants is included in the Pharmacy Quality Scheme (PQS) 2023/24. If contractors choose to not participate in PQS,
Read moreFrom May 30th we will be known as Community Pharmacy England, with new branding designed to be more impactful and authoritative, helping us to better represent community pharmacy. Alongside the name change we will be starting to implement a new engagement and communications strategy to open up a better dialogue with pharmacy owners (our members). This is
Read morePSNC and others have issued a statement on the wellbeing of the pharmacy workforce, recognising their shared endeavour to support pharmacy teams across all sectors to deliver patient care. The Royal Pharmaceutical Society (RPS) and Pharmacist Support hosted a roundtable to discuss the impact of pharmacy workforce wellbeing on patient safety. PSNC Director of Contractor
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Micronised Progesterone (Utrogestan®) 100mg capsules. MSN/2023/052 Tier 2 – medium impact Date of issue 19th May 2023 There are intermittent supplies of micronised progesterone (Utrogestan®) 100mg capsules until late 2023, resulting in brief periods every month when this product will be
Read more
